Webinar Sponsored By:
|Companies are using product licensing, patent transactions, mergers and acquisitions to build patent portfolios for various reasons and as part of new growth strategies. But searching in the life sciences and biochemical technology areas is extraordinarily complex and projects require multiple people to be aligned on goals and strategies.
Searching for advances in chemistry and related sciences requires human intelligence and a wealth of specialized knowledge. The key insights such searching can provide is a critically important part of due diligence for any high-stakes deals.
While there is a need to preserve capital and cut costs, to the greatest extent reasonably possible, success in these initiatives is of paramount importance.
Join Gene Quinn, President & CEO of IPWatchdog, Inc., and one of the most influential people in the intellectual property world, along with Heidi Berven, Ph.D, a Partner and at Honigman and co-leader of the Patent Practice group, and Matthew McBride, Director of IP Search at CAS for a wide-ranging conversation on the importance of searching for high-stakes deals and the difficulties associated with achieving acceptable levels of certainty for the business objective without breaking the bank.